HemaCare Acquired For $380M
socalTECH
DECEMBER 16, 2019
Northridge-based HemaCare , which develops products for the cell therapy market, has been acquired by Charles River Laboratories International , in a deal worth $380M in cash, the companies announced early this morning. READ MORE>>.
Let's personalize your content